|
市場調査レポート
商品コード
1397603
糖尿病用フットウェアの世界市場規模、シェア、産業動向分析レポート:エンドユーザー別、タイプ別、流通チャネル別、地域別展望と予測、2023年~2030年Global Diabetic Footwear Market Size, Share & Industry Trends Analysis Report By End User, By Type (Shoes, Sandals and Slippers), By Distribution Channel (Specialty Stores, Footwear Stores and Others), By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
糖尿病用フットウェアの世界市場規模、シェア、産業動向分析レポート:エンドユーザー別、タイプ別、流通チャネル別、地域別展望と予測、2023年~2030年 |
出版日: 2023年12月15日
発行: KBV Research
ページ情報: 英文 340 Pages
納期: 即納可能
![]() |
糖尿病用フットウェア市場規模は、予測期間中にCAGR 8.0%で成長し、2030年には130億米ドルに達すると予測されます。2022年の市場規模は1億7,547万1,800数で、成長率は8.0%(2019~2022年)です。
しかし、ヘルスケア専門家や糖尿病患者を対象とした教育的取り組みが不足している可能性があります。糖尿病用フットウェアの利点に焦点を当てた意識向上プログラムや教育キャンペーンの不足は、足の合併症予防におけるフットウェアの役割に対する理解の低下を招く可能性があります。一般開業医や一部の専門医を含むヘルスケア専門家は、教育期間中に糖尿病フットケアに関する十分なトレーニングを受けていない可能性があります。専門的なフットウェアの重要性や合併症予防におけるその役割に触れる機会が限られているため、患者に積極的に勧めることができない可能性があります。こうした側面が市場の成長を制限すると予想されます。
さらに、パンデミックは世界のサプライチェーンを混乱させ、糖尿病用シューズを含む様々な商品の生産と流通に影響を与えました。戸締まり、社会的距離の取り方、経済の不確実性などが消費者の行動に影響を与えました。医療・整形外科用シューズ専門店を含む多くの小売店は、臨時休業、人通りの減少、消費者の買い物習慣の変化などの課題に直面しました。これは、従来の実店舗チャネルを通じた糖尿病用シューズの販売に影響を与えました。このため、COVID-19の流行は市場に中程度の影響を与えました。
エンドユーザーの展望
エンドユーザー別に見ると、市場は男性と女性に二分されます。2022年には、女性セグメントが市場で最大の売上シェアを占めました。健康とウェルネスの重要性が高まる中、糖尿病などの慢性疾患を積極的に管理する女性が増えています。この積極的なアプローチは足の健康にも及んでおり、女性は必要な医療サポートを提供し、ライフスタイルやファッションの好みに合ったフットウェアを求めています。従来の糖尿病用フットウェアは、臨床的で実用的な外観を連想させることが多かっています。しかし、業界はよりスタイリッシュなデザインへとシフトしています。このようなファッション動向の進化は、特に女性にとって魅力的であり、女性は自分のスタイルを引き立てる糖尿病用シューズをますます求めるようになっています。このような要因が、今後の同分野の成長を後押しすると思われます。
タイプ別の展望
タイプ別に見ると、市場は靴、サンダル、スリッパに区分されます。2022年には、サンダル部門が市場で大きな収益シェアを獲得しました。サンダルは本来、快適さと履きやすさに関連しています。糖尿病患者の靴は、足の知覚過敏や神経障害の可能性があるため、快適さを優先することが多いです。サンダルは開放的で通気性の良いデザインで、足の合併症につながる摩擦や圧迫のリスクを軽減します。その結果、この分野での需要が高まると思われます。
流通チャネルの展望
流通チャネルに基づき、市場は専門店、靴専門店、オンラインプラットフォーム、その他に分けられます。専門店セグメントは、2022年の市場で最大の収益シェアを記録しました。専門店は多くの場合、靴の専門家、足病医、糖尿病教育者などの知識豊富なスタッフを雇用しています。これらの専門家は、神経障害や足の変形など、個人の特定の足の状態に基づいて、最も適切な糖尿病用靴を選択するための専門的な指導を行うことができます。専門店で提供される個別相談は、ショッピング体験を向上させ、顧客が靴について十分な情報を得た上で決定できるようにします。そのため、このセグメントの需要は増加すると思われます。
地域別展望
地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAに区分されます。北米セグメントは、2022年の市場で最も高い収益シェアを獲得しました。北米、特に米国とカナダは糖尿病の有病率が比較的高いです。糖尿病と診断される人の増加により、足潰瘍などの合併症を予防するための糖尿病専用シューズの需要が高まっています。北米では人口の高齢化が進んでおり、糖尿病やそれに関連する合併症が起こりやすくなっています。高齢者は足の問題を発症するリスクが高いため、この層特有のフットケア要件に対応する糖尿病用シューズのニーズが高まっています。こうした側面から、この分野には有利な成長が見込まれます。
The Global Diabetic Footwear Market size is expected to reach $13 billion by 2030, rising at a market growth of 8.0% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,75,471.8 thousand Units experiencing a growth of 8.0% (2019-2022).
Diabetes, both type 1 and type 2, has been on the rise in many European countries. Type 2 diabetes, which is often associated with lifestyle factors, has shown a particularly notable increase. Therefore, Europe segment generated $2,105.7 million revenue in the market in 2022. Europe has been experiencing a rise in diabetes prevalence, attributed to factors such as sedentary lifestyles, unhealthy diets, and an aging population. In order to prevent complications such as foot ulceration, the demand for specialized products such as diabetic footwear increases in tandem with the prevalence of diabetes. As a result, these factors will help in the expansion of the segment. Some of the factors impacting the market are rising number of diabetic patients worldwide, growing aging population in several nations and lack of understanding of the importance of diabetic footwear.
The global increase in the prevalence of diabetes presents a significant public health challenge. With rising urbanization, sedentary lifestyles, and dietary changes, there has been a substantial surge in the number of individuals diagnosed with diabetes worldwide. This increase is particularly noticeable in low- and middle-income countries, where rapid urbanization has led to shifts in dietary patterns and reduced physical activity levels, contributing to the diabetes epidemic. Additionally, the risk of developing diabetes tends to grow with age. Changes in metabolism often accompany aging, reduced physical activity, and an increased likelihood of other health conditions such as obesity and cardiovascular diseases. As a result, a larger proportion of the aging population is diagnosed with diabetes, contributing to the overall rise in diabetes prevalence. Neuropathy can lead to decreased awareness of pain and discomfort, making older adults less likely to notice foot injuries or abnormalities without careful examination. Therefore, these aspects will drive the demand for diabetic footwear in the coming years and these factors will boost the demand in the market.
However, there may be a deficiency in educational initiatives targeting healthcare professionals and individuals with diabetes. A lack of awareness programs and educational campaigns focused on the benefits of diabetic footwear can result in a reduced understanding of its role in preventing foot complications. Healthcare professionals, including general practitioners and even some specialists, may not receive adequate training on diabetic foot care during their education. Limited exposure to the importance of specialized footwear and its role in preventing complications can lead to a lack of proactive patient recommendations. These aspects are expected to limit the growth of the market.
Additionally, the pandemic disrupted global supply chains, affecting the production and distribution of various goods, including diabetic footwear. Lockdowns, social distancing measures, and economic uncertainties influenced consumer behavior. Many retail outlets, including those specializing in medical and orthopedic footwear, faced challenges such as temporary closures, reduced foot traffic, and changes in consumer shopping habits. This affected the sales of diabetic footwear through traditional brick-and-mortar channels. Thus, the COVID-19 pandemic moderately impacted the market.
End User Outlook
On the basis of end user, the market is bifurcated into men and women. In 2022, the women segment witnessed the maximum revenue share in the market. With an increasing importance on health and wellness, more women are proactively managing chronic conditions like diabetes. This proactive approach extends to foot health, and women are seeking footwear that provides the necessary medical support and aligns with their lifestyle and fashion preferences. Traditional diabetic footwear has often been associated with a clinical and utilitarian appearance. However, the industry is shifting towards more stylish designs. This evolution in fashion trends is particularly appealing to women, who are increasingly looking for diabetic footwear that complements their style. These factors will help in the growth of the segment in future.
Type Outlook
Based on type, the market is segmented into shoes, sandals, and slippers. In 2022, the sandals segment garnered a significant revenue share in the market. Sandals are inherently associated with comfort and ease of wear. In the context of diabetic footwear, individuals with diabetes often prioritize comfort due to potential foot sensitivity and neuropathy. Sandals provide an open and breathable design, reducing the risk of friction and pressure points that can lead to foot complications. As a result, there will be increased demand in the segment.
Distribution Channel Outlook
Based on distribution channel, the market is divided into specialty stores, footwear stores, online platform, and others. The specialty stores segment recorded the maximum revenue share in the market in 2022. Specialty stores often employ knowledgeable staff, including footwear specialists, podiatrists, and diabetes educators. These professionals can provide expert guidance on selecting the most appropriate diabetic footwear based on an individual's specific foot conditions, such as neuropathy or foot deformities. The personalized consultation offered in specialty stores enhances the shopping experience and ensures customers make informed decisions about their footwear. Therefore, there will be increased demand in the segment.
Regional Outlook
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America, particularly the United States and Canada, has a relatively high prevalence of diabetes. The increasing number of individuals diagnosed with diabetes has contributed to a growing demand for specialized diabetic footwear to prevent complications, including foot ulcers. The aging population in North America is more prone to diabetes and related complications. As older people are at a higher risk of developing foot problems, there is an increasing need for diabetic footwear to address this demographic's specific foot care requirements. These aspects will pose lucrative growth prospects for the segment.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New Balance Athletics, Inc., SKECHERS USA, Inc., Orthofeet, Inc. (Webster Equity Partners), DJO Global (Enovis Corporation), Drew Shoe Corporation, Wolverine World Wide, Inc., Podartis Srl, I-Runner (Healer Health LLC), Pilgrim Shoes and Aetrx Worldwide, Inc.
Strategies Deployed in Diabetic Footwear Market
Apr-2023: Skechers took over Sports Connection Holding, a Scandinavia-based operator of distributor business. This acquisition aimed to broaden the company's customer reach in Europe.
Sep-2022: Aetrx Worldwide, Inc. unveiled Foot.com Data Portal, a dedicated platform. The launched product would support shoe manufacturers around the world to create better-fitting footwear. Additionally, customers could view and extract global 3D foot data broken down by gender, foot size, country, and more.
Jun-2022: Skechers signed an agreement with Lodha, a real estate developer. The agreement involves Lodha setting up a new 1.1 million square foot distribution center for Skechers in Maharashtra, India. This new distribution has the potential to expand the footwear company's business and distribution capabilities. Additionally, this new center demonstrates Skecher's devotion to the Indian market.
Jun-2021: Aetrex Worldwide, Inc. introduced Albert 3DFit, a sleek and modern 3D foot scanner. The launched product would be designed to revolutionize the retail industry by making 3D fit technology available to stores of all sizes. Additionally, the launched product could calculate the client's 3D foot measurements in less than 10 seconds with accuracy up to 1 millimeter.
Sep-2020: Aetrex came into partnership with EOS, a leading German 3D printer manufacturer. The partnership was focused on developing its thinnest orthotic insole. Orthotic insole is a removable shoe insert, also known as a foot orthosis, which is used for therapeutic purposes.
Oct-2019: New Balance collaborated with FIGS, a medical apparel company. Following this collaboration, New Balance launched its first capsule collection for bringing functional and fashionable footwear to the healthcare community. This collection was launched with two styles for women and one for men, the FIGS x New Balance collection focuses on lightweight and durable performance features that meet the unique demands of medical professionals, residents and students.
Jun-2019: New Balance launched the Zante Generate shoe with a 3D printed midsole, the first 3D printed sneaker. The launched product would be the optimal balance of flexibility, strength, and durability due to the Zante Generate's intricate honeycomb midsole structure.
Feb-2019: Skechers acquired Future Group's stake in the joint venture. The acquisition of Future's stake in the joint venture broadens the footwear company's retail network in the South Asia region. Further, the acquisition advances the acquiring company's operations and intensifies its growth plans.
Market Segments covered in the Report:
By End User (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Distribution Channel (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Billion/Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research